Table 6. Malignancies at 36 monthsa

SRL-CsA-ST (n = 215)SRL-ST (n = 215)P Valueb
a PTLD, posttransplant lymphoproliferative disease.
b Fisher exact test for pairwise comparison, SRL-CsA-ST versus SRL-ST.
Total11.2%5.6%0.054
Skin cancer6.5%3.7%0.274
PTLD/lymphoma1.4%0.5%0.623
Other3.3%1.4%0.338